Latest Insider Transactions at Mersana Therapeutics, Inc. (MRSN)
This section provides a real-time view of insider transactions for Mersana Therapeutics, Inc. (MRSN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Mersana Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Mersana Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 15
2021
|
Anna Protopapas Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,198
-2.26%
|
$109,158
$21.09 P/Share
|
|
Jan 15
2021
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,709
+7.15%
|
-
|
|
Jan 15
2021
|
Brian De Schuytner SVP, COO & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,162
-15.32%
|
$24,402
$21.09 P/Share
|
|
Jan 15
2021
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,959
+34.29%
|
-
|
|
Jan 15
2021
|
Michael J. Kaufman Chief Manufacturing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,957
-29.35%
|
$41,097
$21.09 P/Share
|
|
Jan 15
2021
|
Michael J. Kaufman Chief Manufacturing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,667
+50.0%
|
-
|
|
Jan 15
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,324
-6.88%
|
$48,804
$21.09 P/Share
|
|
Jan 15
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,917
+18.99%
|
-
|
|
Jan 12
2021
|
Andrew A. F. Hack |
BUY
Open market or private purchase
|
Indirect |
75,000
+1.99%
|
$1,350,000
$18.16 P/Share
|
|
Jan 11
2021
|
Andrew A. F. Hack |
BUY
Open market or private purchase
|
Indirect |
75,000
+2.03%
|
$1,350,000
$18.52 P/Share
|
|
Jan 08
2021
|
Andrew A. F. Hack |
BUY
Open market or private purchase
|
Indirect |
100,000
+2.74%
|
$1,800,000
$18.39 P/Share
|
|
Jan 04
2021
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
247
-100.0%
|
$6,422
$26.76 P/Share
|
|
Dec 28
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+25.82%
|
$9,000
$1.4 P/Share
|
|
Dec 21
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
8,203
-100.0%
|
$205,075
$25.6 P/Share
|
|
Dec 21
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,203
+50.0%
|
$32,812
$4.84 P/Share
|
|
Dec 14
2020
|
David M Mott Director |
BUY
Other acquisition or disposition
|
Indirect |
1,582
+7.78%
|
-
|
|
Dec 01
2020
|
David M Mott Director |
BUY
Other acquisition or disposition
|
Indirect |
1,613
+9.38%
|
-
|
|
Nov 20
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
8,203
-100.0%
|
$188,669
$23.05 P/Share
|
|
Nov 20
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,203
+50.0%
|
$32,812
$4.84 P/Share
|
|
Nov 09
2020
|
David M Mott Director |
BUY
Other acquisition or disposition
|
Indirect |
1,608
+11.69%
|
-
|
|
Oct 21
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
4,101
-10.84%
|
$69,717
$17.5 P/Share
|
|
Oct 21
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,101
+9.78%
|
$16,404
$4.84 P/Share
|
|
Oct 20
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,953
+49.37%
|
$83,812
$4.63 P/Share
|
|
Oct 20
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
4,102
-100.0%
|
$65,632
$16.74 P/Share
|
|
Sep 14
2020
|
David M Mott Director |
BUY
Other acquisition or disposition
|
Indirect |
1,602
+14.93%
|
-
|